Real-world lung cancer screening populations are older and sicker than those in the National Lung Screening Trial. Older age and more comorbidities may reduce the benefits of lung cancer screening.

Transmedics Group (($TMDX)) announced an update on their ongoing clinical study. The US National OCS Lung Thoracic Organ Perfusion (TOP) Registry, ...

Please provide your email address to receive an email when new articles are posted on . Three measures of lung function improved between baseline and 12 months. Observed improvements were not as large ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company focused on the need for noninvasive, accurate tests for the detection of early-stage lung ...

The Study presents a novel approach to improving the global applicability of clinical trial outcomes by assessing how well results from controlled trials translate to real-world patient populations.

New research presented at the 2025 Society of Thoracic Surgeons (STS) Annual Meeting reveals that anatomic lung resections, such as lobectomy and segmentectomy, are associated with improved long-term ...

LOS ANGELES -- Surgeries to remove small tumors in stage IA non-small cell lung cancer (NSCLC) were associated with varying odds of long-term survival depending on the amount of lung removed, based on ...

Registry of Genetic Alterations of Taiwan Non–Small Cell Lung Cancer by Comprehensive Next-Generation Sequencing: A Real-World Cohort Study-Taiwan Cooperative Oncology Group T1521 Tissue inadequacy ...

Are your lungs holding you back, and is mucus buildup to blame? RespiClear, A new science-backed solution might finally offer real, long-term relief in 2025. BEVERLY HILLS, FL / ACCESS Newswire / ...

Lutathera showed antitumor activity in metastatic BP-NETs, with partial responses in 17% of patients and stable disease in 30%. The study reported a median progression-free survival of 10.8 months and ...